Abstract
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors) provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute. These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating these events offer hope for therapeutic intervention.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dore, G. J. et al. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 16, 39–43 (1997).
Ferrando, S. et al. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12, F65–F70 (1998).
Dore, G. J. et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13, 1249–1253 (1999).
Major, E. O., Rausch, D., Marra, C. & Clifford, D. HIV-associated dementia. Science 288, 440–442 (2000).
Clifford, D. B. Human immunodeficiency virus-associated dementia. Arch. Neurol. 57, 321–324 (2000).
Lipton, S. A. Treating AIDS dementia. Science 276, 1629–1630 (1997).
Lipton, S. A. & Gendelman, H. E. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332, 934–940 (1995).
McArthur, J. C. et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43, 2245–2252 (1993).
Ellis, R. J. et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch. Neurol. 54, 416–424 (1997).
Sacktor, N. et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56, 257–260 (2001).
Enting, R. H. et al. Antiretroviral drugs and the central nervous system. AIDS 12, 1941–1955 (1998).
Gartner, S. HIV infection and dementia. Science 287, 602–604 (2000).
Cunningham, P. H., Smith, D. G., Satchell, C., Cooper, D. A. & Brew, B. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14, 1949–1954 (2000).
Asensio, V. C. & Campbell, I. L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends. Neurosci. 22, 504–512 (1999).
Prospero-Garcia, O. et al. Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc. Natl Acad. Sci. USA 93, 14158–14163 (1996).
Kalams, S. A. & Walker, B. D. Cytotoxic T lymphocytes and HIV-1 related neurologic disorders. Curr. Top. Microbiol. Immunol. 202, 79–88 (1995).
Sasseville, V. G. et al. Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am. J. Pathol. 144, 27–40 (1994).
Fiala, M. et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3, 553–564 (1997).
Toneatto, S., Finco, O., van der Putten, H., Abrignani, S. & Annunziata, P. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13, 2343–2348 (1999).
Brew, B. J., Pemberton, L., Cunningham, P. & Law, M. G. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 175, 963–966 (1997).
Ellis, R. J. et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann. Neurol. 42, 679–688 (1997).
McArthur, J. C. et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42, 689–698 (1997).
Wiley, C. A. et al. Distribution of brain HIV load in AIDS. Brain. Pathol. 8, 277–284 (1998).
Glass, J. D., Fedor, H., Wesselingh, S. L. & McArthur, J. C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38, 755–762 (1995).
Masliah, E. et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann. Neurol. 42, 963–972 (1997).
Wesselingh, S. L. et al. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J. Neuroimmunol. 74, 1–8 (1997).
Giulian, D. et al. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 16, 3139–3153 (1996).
Heyes, M. P. et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29, 202–209 (1991).
Everall, I. P. et al. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain. Pathol. 9, 209–217 (1999).
Fox, L., Alford, M., Achim, C., Mallory, M. & Masliah, E. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56, 360–368 (1997).
Masliah, E., Ge, N., Achim, C. L., Hansen, L. A. & Wiley, C. A. Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51, 585–593 (1992).
Adle-Biassette, H. et al. Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21, 218–227 (1995).
Gelbard, H. A. et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21, 208–217 (1995).
Petito, C. K. & Roberts, B. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146, 1121–1130 (1995).
Adle-Biassette, H. et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25, 123–133 (1999).
Giulian, D., Vaca, K. & Noonan, C. A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250, 1593–1596 (1990).
Giulian, D., Wendt, E., Vaca, K. & Noonan, C. A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl Acad. Sci. USA 90, 2769–2773 (1993).
Lipton, S. A., Sucher, N. J., Kaiser, P. K. & Dreyer, E. B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7, 111–118 (1991).
Brew, B. J. et al. Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J. Neurovirol. 1, 369–374 (1995).
Yeh, M. W. et al. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l-cysteine. J. Immunol. 164, 4265–4270 (2000).
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162–7166 (1995).
Meucci, O. et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl Acad. Sci. USA 95, 14500–14505 (1998).
Liu, Y. et al. Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nature Med. 6, 1380–1387 (2000).
He, J. et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645–649 (1997).
Michael, N. L. & Moore, J. P. HIV-1 entry inhibitors: evading the issue. Nature Med. 5, 740–742 (1999).
Rottman, J. B. et al. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151, 1341–1351 (1997).
Kaul, M. & Lipton, S. A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl Acad. Sci. USA 96, 8212–8216 (1999).
Zheng, J. et al. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98, 185–200 (1999).
Sanders, V. J. et al. Chemokines and receptors in HIV encephalitis. AIDS 12, 1021–1026 (1998).
McManus, C. M. et al. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am. J. Pathol. 156, 1441–1453 (2000).
Zhang, L. et al. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72, 5035–5045 (1998).
Limatola, C. et al. SDF-1α-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 12, 2497–2504 (2000).
Lazarini, F. et al. Differential signalling of the chemokine receptor CXCR4 by stromal cell- derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur. J. Neurosci. 12, 117–125 (2000).
Ohagen, A. et al. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J. Virol. 73, 897–906 (1999).
Hesselgesser, J. et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4. Curr. Biol. 8, 595–598 (1998).
Letendre, S. L., Lanier, E. R. & McCutchan, J. A. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J. Infect. Dis. 180, 310–319 (1999).
Cinque, P. et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12, 1327–1332 (1998).
Kelder, W., McArthur, J. C., Nance-Sproson, T., McClernon, D. & Griffin, D. E. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 44, 831–835 (1998).
Combadiere, C. et al. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J. Biol. Chem. 273, 23799–23804 (1998).
Tong, N. et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164, 1333–1339 (2000).
Meucci, O., Fatatis, A., Simen, A. A. & Miller, R. J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl Acad. Sci. USA 97, 8075–8080 (2000).
Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R. & Bacon, K. B. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 163, 1628–1635 (1999).
Chapman, G. A. et al. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20, RC87 (2000).
Canki, M. et al. Isolation and long-term culture of primary ocular human immunodeficiency virus type 1 isolates in primary astrocytes. J. Neurovirol. 3, 10–15 (1997).
Dreyer, E. B., Kaiser, P. K., Offermann, J. T. & Lipton, S. A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248, 364–367 (1990).
Bhat, N. R., Zhang, P., Lee, J. C. & Hogan, E. L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633–1641 (1998).
Toggas, S. M. et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188–193 (1994).
Wyss-Coray, T. et al. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97, 789–798 (1996).
Fine, S. M. et al. Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271, 15303–15306 (1996).
Genis, P. et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 1703–1718 (1992).
Bezzi, P. et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281–285 (1998).
Conant, K. et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl Acad. Sci. USA 95, 3117–3121 (1998).
Adamson, D. C. et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917–1921 (1996).
Hesselgesser, J. et al. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7, 112–121 (1997).
Fontana, G., Valenti, L. & Raiteri, M. gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J. Neurosci. Res. 49, 732–738 (1997).
Nath, A. et al. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47, 186–194 (2000).
Piller, S. C., Jans, P., Gage, P. W. & Jans, D. A. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc. Natl Acad. Sci. USA 95, 4595–4600 (1998).
Shi, B. et al. Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Invest. 98, 1979–1990 (1996).
Xiong, H. et al. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J. Neurovirol. 6(Suppl. 1), S14–S23 (2000).
Pulliam, L., Herndier, B. G., Tang, N. M. & McGrath, M. S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87, 503–512 (1991).
Brenneman, D. E. et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335, 639–642 (1988).
Lipton, S. A. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends. Neurosci. 16, 527–532 (1993).
Gendelman, H. E., Genis, P., Jett, M., Zhai, Q. H. & Nottet, H. S. An experimental model system for HIV-1-induced brain injury. Adv. Neuroimmunol. 4, 189–193 (1994).
Toggas, S. M., Masliah, E. & Mucke, L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain. Res. 706, 303–307 (1996).
Budd, S. L., Tenneti, L., Lishnak, T. & Lipton, S. A. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl Acad. Sci. USA 97, 6161–6166 (2000).
Tenneti, L., D'Emilia, D. M., Troy, C. M. & Lipton, S. A. Role of caspases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71, 946–959 (1998).
Ghatan, S. et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150, 335–347 (2000).
Garden, G. A., Budd, S. L., Kaul, M. & Lipton, S. A. HIV-gp120 induces apoptosis in cultured cortical neurons by pathways involving caspases 8 and 9 and TNF-α. Soc. Neurosci. Abstr. 26, 1062 (2000).
Pulliam, L., Zhou, M., Stubblebine, M. & Bitler, C. M. Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J. Neurosci. Res. 54, 530–538 (1998).
Shi, B., Raina, J., Lorenzo, A., Busciglio, J. & Gabuzda, D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4, 281–290 (1998).
Lipton, S. A. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42, 1403–1405 (1992).
Schifitto, G. et al. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology 53, 391–396 (1999).
Navia, B. A. et al. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 51, 221–228 (1998).
Sacktor, N. et al. Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology 54, 233–235 (2000).
Bruno, V., Copani, A., Besong, G., Scoto, G. & Nicoletti, F. Neuroprotective activity of chemokines against N-methyl-d-aspartate or β-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 399, 117–121 (2000).
Yuan, J. & Yankner, B. A. Apoptosis in the nervous system. Nature 407, 802–809 (2000).
Acknowledgements
We dedicate this work to the memory of T. Sandson for his compassionate treatment of patients with HIV-associated dementia. We sincerely apologize to our colleagues whose works we could not cite owing to space and reference limitations. We thank members of our laboratory for their hard work and helpful discussions. M.K. is supported by the American Foundation for AIDS Research. S.A.L. and G.A.G. are supported by the National Institutes of Health. S.A.L. is or has recently been a consultant to Allergan, Alcon and Neurobiologicial Technologies, Inc. in the field of neuroprotective agents.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kaul, M., Garden, G. & Lipton, S. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988–994 (2001). https://doi.org/10.1038/35073667
Issue Date:
DOI: https://doi.org/10.1038/35073667
This article is cited by
-
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
Nature Reviews Neurology (2023)
-
Additive cortical gray matter deficits in people living with HIV who use cocaine
Journal of NeuroVirology (2023)
-
Study of disorders in regulatory spatiotemporal neurodynamics of calcium and nitric oxide
Cognitive Neurodynamics (2023)
-
Development of nanoemulsion of antiviral drug for brain targeting in the treatment of neuro-AIDS
Beni-Suef University Journal of Basic and Applied Sciences (2022)
-
Synergistic Effect and Mechanism of Apoptosis Induction by Morphine and the HIV-1gp120V3 Loop in Hippocampal Neurons
Journal of Neuroimmune Pharmacology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.